1. Home
  2. WVE vs CTGO Comparison

WVE vs CTGO Comparison

Compare WVE & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.88

Market Cap

744.8M

Sector

Health Care

ML Signal

N/A

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

N/A

Current Price

$16.87

Market Cap

609.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
CTGO
Founded
2012
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
609.7M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
WVE
CTGO
Price
$3.88
$16.87
Analyst Decision
Strong Buy
Buy
Analyst Count
18
6
Target Price
$18.53
★ $31.17
AVG Volume (30 Days)
★ 2.8M
328.6K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.77
EPS
N/A
★ N/A
Revenue
★ $3,704,000.00
N/A
Revenue This Year
$20.53
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.56
$14.50
52 Week High
$21.73
$34.38

Technical Indicators

Market Signals
Indicator
WVE
CTGO
Relative Strength Index (RSI) 36.57 38.69
Support Level N/A $14.99
Resistance Level $6.33 $17.92
Average True Range (ATR) 0.21 0.88
MACD -0.02 -0.28
Stochastic Oscillator 38.99 10.77

Price Performance

Historical Comparison
WVE
CTGO

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CTGO Contango ORE Inc.

Contango Silver & Gold Inc, formerly Contango Ore Inc operates in the United States. The company is engaged in the exploration for and development of gold ore and associated minerals in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin, whose governmental entity is the Tetlin Tribal Council, for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

Share on Social Networks: